Princeton Alpha Management’s Cytokinetics CYTK Stock Holding History

Princeton Alpha Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-19,994	Closed	-$136K	–	738
2015 Q1	$136K	Buy	+19,994	New	+$149K	0.03%	646
2014 Q3	–	Sell	-23,808	Closed	-$114K	–	693
2014 Q2	$114K	Buy	23,808 +12,698	+114%	+$77.5K	0.02%	627
2014 Q1	$106K	Buy	+11,110	New	+$100K	0.03%	590

Other funds holding CYTK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LPU

Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Princeton Alpha Management's CYTK Position: Q2 2015 in Review

Princeton Alpha Management sold out of Cytokinetics (CYTK) in Q2 2015, closing a stake of 19,994 shares — an estimated $136K sold.

Princeton Alpha Management first reported a position in CYTK in Q1 2014 and held it in 3 quarters. The position peaked at $136K in Q1 2015. 99 funds tracked by Wall St. Rank hold CYTK as of Q2 2015.

Princeton Alpha Management reported no remaining Cytokinetics position as of Q2 2015 after selling out during the quarter.
Princeton Alpha Management sold 19,994 Cytokinetics shares in Q2 2015, an estimated $136K.
Princeton Alpha Management first reported a position in Cytokinetics in Q1 2014 and held it in 3 quarters.
Princeton Alpha Management's Cytokinetics position peaked at $136K in Q1 2015.
99 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2015.

Based on Princeton Alpha Management's 13F filing for Q2 2015, filed 7 Aug 2015.